LOARGYS Trademark

Trademark Overview


On Monday, September 23, 2019, a trademark application was filed for LOARGYS with the United States Patent and Trademark Office. The USPTO has given the LOARGYS trademark a serial number of 88627216. The federal status of this trademark filing is REGISTERED as of Tuesday, April 18, 2023. This trademark is owned by Aeglea BioTherapeutics, Inc.. The LOARGYS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of rare genetic diseases; pharmaceutical preparations for the treatment of Arginase 1 deficiency; pharmaceutical preparations for the treatment of cancer; biopharmaceutical preparations for the treatment of rare genetic diseases; biopharmaceutical preparations for the treatment of Arginase 1 deficiency; biopharmaceutical preparations for the treatment of cancer; biotherapeutic preparations for the treatment of rare genetic diseases; biotherapeutic preparations for the treatment of Arginase 1 deficiency; biotherapeutic preparations for the treatment of cancer; biotherapeutic preparations and substances for the treatment of rare genetic diseases; biotherapeutic preparations and substances for the treatment of Arginase 1 deficiency; biotherapeutic preparations and substances for the treatment of cancer; enzyme replacement therapy preparations for medical purposes
loargys

General Information


Serial Number88627216
Word MarkLOARGYS
Filing DateMonday, September 23, 2019
Status700 - REGISTERED
Status DateTuesday, April 18, 2023
Registration Number7031345
Registration DateTuesday, April 18, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 14, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of rare genetic diseases; pharmaceutical preparations for the treatment of Arginase 1 deficiency; pharmaceutical preparations for the treatment of cancer; biopharmaceutical preparations for the treatment of rare genetic diseases; biopharmaceutical preparations for the treatment of Arginase 1 deficiency; biopharmaceutical preparations for the treatment of cancer; biotherapeutic preparations for the treatment of rare genetic diseases; biotherapeutic preparations for the treatment of Arginase 1 deficiency; biotherapeutic preparations for the treatment of cancer; biotherapeutic preparations and substances for the treatment of rare genetic diseases; biotherapeutic preparations and substances for the treatment of Arginase 1 deficiency; biotherapeutic preparations and substances for the treatment of cancer; enzyme replacement therapy preparations for medical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 27, 2019
Primary Code005
First Use Anywhere DateTuesday, March 7, 2023
First Use In Commerce DateTuesday, March 7, 2023

Trademark Owner History


Party NameIMMEDICA PHARMA AB
Party Type31 - New Owner After Registration
Legal Entity Type64 - NOT AVAILABLE
AddressSTOCKHOLM 113 63
SE

Party NameAeglea BioTherapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAustin, TX 78746

Party NameAeglea BioTherapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAustin, TX 78746

Party NameAeglea BioTherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAustin, TX 78746

Trademark Events


Event DateEvent Description
Wednesday, December 6, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, April 18, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 18, 2023REGISTERED-PRINCIPAL REGISTER
Saturday, March 11, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, March 10, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, March 10, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 8, 2023USE AMENDMENT FILED
Wednesday, March 8, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, December 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 28, 2022SOU EXTENSION 5 GRANTED
Friday, December 9, 2022SOU EXTENSION 5 FILED
Wednesday, December 28, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 9, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, May 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 29, 2022SOU EXTENSION 4 GRANTED
Friday, April 29, 2022SOU EXTENSION 4 FILED
Friday, April 29, 2022SOU TEAS EXTENSION RECEIVED
Friday, December 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 8, 2021SOU EXTENSION 3 GRANTED
Wednesday, December 8, 2021SOU EXTENSION 3 FILED
Wednesday, December 8, 2021SOU TEAS EXTENSION RECEIVED
Thursday, June 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 8, 2021SOU EXTENSION 2 GRANTED
Tuesday, June 8, 2021SOU EXTENSION 2 FILED
Tuesday, June 8, 2021SOU TEAS EXTENSION RECEIVED
Saturday, December 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 3, 2020SOU EXTENSION 1 GRANTED
Thursday, December 3, 2020SOU EXTENSION 1 FILED
Thursday, December 3, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, June 9, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 14, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 14, 2020PUBLISHED FOR OPPOSITION
Wednesday, March 25, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 10, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 2, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 2, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 2, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 23, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 23, 2019NON-FINAL ACTION E-MAILED
Monday, December 23, 2019NON-FINAL ACTION WRITTEN
Monday, December 23, 2019ASSIGNED TO EXAMINER
Friday, September 27, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 26, 2019NEW APPLICATION ENTERED